Autosomal dominant polycystic kidney disease

Clinical Medicine, Journal of the Royal College of Physicians of London

Volumn 9, Issue 3, 2009, Pages 278-283

  Chow, Chem Li ^a   Ong, Albert C M ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; POLYCYSTIN; POLYCYSTIN 1; POLYCYSTIN 2; POLYCYSTIN 3; UNCLASSIFIED DRUG;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; BLEEDING; BRAIN ARTERY ANEURYSM; CANCER RISK; CLINICAL FEATURE; COIL EMBOLIZATION; CONSERVATIVE TREATMENT; FAMILY ASSESSMENT; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; HEMATURIA; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY POLYCYSTIC DISEASE; LAPAROSCOPIC SURGERY; LIFESTYLE MODIFICATION; LIVER CYST; NEPHRECTOMY; NEPHROLITHIASIS; PAIN; PANCREAS CYST; PATHOPHYSIOLOGY; PREGNANCY; SYMPTOM; URINARY TRACT INFECTION; COUNSELING; CYST; FEMALE; FLANK PAIN; GENETICS; INTRACRANIAL ANEURYSM; LIVER DISEASE; PREGNANCY COMPLICATION;

COUNSELING; CYSTS; FEMALE; FLANK PAIN; GENETIC SCREENING; HEMATURIA; HEMORRHAGE; HUMANS; HYPERTENSION; INTRACRANIAL ANEURYSM; LIVER DISEASES; NEPHROLITHIASIS; PANCREATIC CYST; POLYCYSTIC KIDNEY DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS; URINARY TRACT INFECTIONS;

EID: 69049090052     PISSN: 14702118     EISSN: 14734893     Source Type: Journal    
DOI: 10.7861/clinmedicine.9-3-278     Document Type: Article

References (23)

1. Ong AC, Harris PC. Molecular pathogenesis of ADPKD: The polycystin complex gets complex. Kidney Int 2005;67: 1234-47.
2. Fick GM, Johnson AM, Hammond WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1995;5:2048-56.
3. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet 2007;369:1287-301.
4. Vora N, Perrone R, Bianchi DW. Reproductive issues for adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 2008;51:307-18.
5. Cobben JM, Breuning MH, Schoots C, ten Kate LP, Zerres K. Congenital hepatic fibrosis in autosomal-dominant polycystic kidney disease. Kidney Int 1990;38:880-5.
6. Pirson Y, Chauveau D, Torres V. Management of cerebral aneurysms in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2002;13:269-76.
7. Torra R, Nicolau C, Badenas C et al. Ultrasonographic study of pancreatic cysts in autosomal dominant polycystic kidney disease. Clin Nephrol 1997;47:19-22.
8. Pei Y, Obaji J, Dupuis A et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol 2008;20:205-12.
9. Ravine D, Gibson RN, Walker RG et al. Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1. Lancet 1994;343:824-7.
10. Grantham JJ, Torres VE, Chapman AB et al. Volume progression in polycystic kidney disease. N Engl J Med 2006;354:2122-30.
11. Rossetti S, Consugar MB, Chapman AB et al. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2007; 18:2143-60.
12. Garcia-Gonzalez MA, Jones JG, Allen SK et al. Evaluating the clinical utility of a molecular genetic test for polycystic kidney disease. Mol Genet Metab 2007;92:160-7.
13. Connor A, Lunt PW, Dolling C et al. Mosaicism in autosomal dominant polycystic kidney disease revealed by genetic testing to enable living related renal transplantation. Am J Transplant 2008; 8:232-7.
14. Consugar MB, Wong WC, Lundquist PA et al. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney Int 2008; 74:1468-79.
15. Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med 2008;359:1477-85.
16. Gibbs GF, Huston J 3rd, Qian Q et al. Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney Int 2004;65:1621-7.
17. Wiebers DO, Whisnant JP, Huston J 3rd et al. Unruptured intracranial aneurysms: Natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet 2003;362:103-10.
18. Schrier RW, Belz MM, Johnson AM et al. Repeat imaging for intracranial aneurysms in patients with autosomal dominant polycystic kidney disease with initially negative studies: A prospective ten-year follow-up. J Am Soc Nephrol 2004;15:1023-8.
19. Hamer RA, Chow CL, Ong AC, McKane WS. Polycystic kidney disease is a risk factor for new-onset diabetes after transplantation. Transplantation 2007; 83:36-40.
20. Zerres K, Rudnik-Schöneborn S, Deget F. Childhood onset autosomal dominant polycystic kidney disease in sibs: Clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft für Pädiatrische Nephrologie). J Med Genet 1993;30:583-8.
21. Wang X, Gattone V 2nd, Harris PC, Torres VE. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol 2005; 16:846-51.
22. Grantham JJ. Does extended-release somatostatin slow the growth of renal cysts in autosomal-dominant polycystic kidney disease? Nat Clin Pract Nephrol 2006;2:66-7.
23. Wahl PR, Serra AL, Le Hir M et al. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD). Nephrol Dial Transplant 2006;21:598-604.